EOS789, pan‐phosphate transporter inhibitor, ameliorates the progression of kidney injury in anti‐GBM‐induced glomerulonephritis rats

Hyperphosphatemia associated with chronic kidney disease (CKD) not only dysregulates mineral metabolism and bone diseases, but also strongly contributes to the progression of kidney disease itself. We have identified a novel drug for hyperphosphatemia, EOS789, that interacts with several sodium‐depe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuboi, Yoshinori, Ichida, Yasuhiro, Murai, Atsuko, Maeda, Akira, Iida, Manami, Kato, Atsuhiko, Ohtomo, Shuichi, Horiba, Naoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137114/
https://www.ncbi.nlm.nih.gov/pubmed/35621227
http://dx.doi.org/10.1002/prp2.973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137114/
https://www.ncbi.nlm.nih.gov/pubmed/35621227
http://dx.doi.org/10.1002/prp2.973

Ejemplares similares